KAVCAPA
Live / Registered — Registered (as of 02 Sept 2025)
What this means for you
Registered since 02 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97569422
- Registration number
- 7924356
- Mark type
- Stylized text
- Filed
- 29 Aug 2022
- Published for opposition
- 12 Mar 2024
- Registered
- 02 Sept 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 02 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 08 Oct 2024 — NOTICE OF ALLOWANCE CANCELLED
- 11 Aug 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jan 2025 — REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED
- 21 Jan 2025 — ASSIGNED TO PETITION STAFF
- 09 Dec 2024 — TEAS REQUEST FOR REINSTATEMENT
- 09 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Oct 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED